No CrossRef data available.
Article contents
Putting contract research organisations on the radar
Published online by Cambridge University Press: 02 January 2018
Extract
Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
There is a trend for pharmaceutical companies to contract third parties to conduct the clinical trials that are needed to test their drugs. This trend is referred to as outsourcing, and the companies that carry out the work are called contract research organisations. In addition, clinical trials are increasingly conducted in non-traditional trial regions, which are mainly low-and middle-income countries. This trend is called offshoring. The combination of outsourcing and offshoring poses serious risks for the ethical treatment of participants in clinical trials.
- Type
- Thematic papers
- Information
- Creative Commons
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.- Copyright
- Copyright © Royal College of Psychiatrists 2012
Footnotes
This article is based on a research report with the same title, published by the Centre for Research on Multinational Corporations (SOMO), Corporate Social and Ethical Research (CSER) and Salud y Farmacos (SyF). It is available from SOMO's website, http://somo.nl/publications-nl/Publication_3615-nl
References
Cipher (2008) Global Contract Research Organization (CRO) Industry: Overview and Trends, 2008. Available at http://www.cipher-sys.com/Global%20Contract%20Research%20Organizations.pdf (accessed 6 March 2012).Google Scholar
Jakovcic, K. (2009) The CRO market outlook: emerging markets, leading players and future trends. Business Insights. Available at http://www.marketresearch.com/Business-Insights-v893/CRO-Outlook-Emerging-leading-players-2428184 (accessed 6 March 2012).Google Scholar
Kim, I. & Kardum, K. (2010) Evotec AG. Close Brothers Seydler, Available at http://ebookbrowse.com/evotec-initial-coverage-2010-07-30-pdf-d109426765 (accessed 6 March 2012).Google Scholar
Mirowski, P. & Van Horn, R. (2005) The contract research organization and the commercialization of scientific research. Social Studies of Science, 35, 503–548.CrossRefGoogle ScholarPubMed
Pharmaceutical Research and Manufacturers of America (2010) Pharmaceutical Industry Profile 2010. Available at http://www.phrma.org/sites/default/files/159/profile_2010_final.pdf (accessed 6 March 2012).Google Scholar
Shuchman, M. (2007) Commercializing clinical trials – risks and benefits of the CRO boom. New England Journal of Medicine, 357, 1365–1368.CrossRefGoogle ScholarPubMed
Thomis, J. & Smita, D. (2006) Outsourcing strategies. In Outsourcing Clinical Development (eds Winter, J. E. & Baguley, J.), p. 14. Gower Publishing.Google Scholar
Tufts Center for the Study of Drug Development (2010) Tufts CSDD Outlook 2010. Available at http://csdd.tufts.edu/_documents/www/Outlook2010.pdf (accessed 6 March 2012).Google Scholar
Wemos (2010) The Globalization of Clinical Trials: Testimonies from Human Subjects. Wemos.Google Scholar
You have
Access
Open access
eLetters
No eLetters have been published for this article.